Stock A003060 APROGEN BIOLOGICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Aprogen Biologics Inc.

Equities

A003060

KR7003060001

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
1,565 KRW -0.13% Intraday chart for Aprogen Biologics Inc. +5.03% -46.03%
Mar. 13 Aprogen Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Aprogen Biologics Inc, formerly Aprogen Pharmaceuticals Inc, is a Korea-based company principally engaged in the pharmaceutical business. The Company operates its business through two segments. The Medicine Business segment is engaged in the manufacture and sale of central nervous system drugs, autonomic agents, arteriosclerosis agents, metabolic agents, circulatory system drugs, biopharmaceuticals and others. The Segment is also engaged in the manufacture and sale of cosmetics such as skin moisturizers and others. The Gaming Business segment is engaged in the development and operation of role-playing games (RPGs).

Number of employees: 363

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
72.1 %
64,743 99.3 % 62,954 72.1 % -2.76%
Bio
19.3 %
274 0.4 % 16,870 19.3 % +6,047.42%
Insulation
7.3 %
- - 6,369 7.3 % -
Other
0.9 %
- - 812 0.9 % -
Game
0.4 %
173 0.3 % 358 0.4 % +106.48%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
65,190 100.0 % 87,364 100.0 % +34.01%

Managers

Managers TitleAgeSince
Jung-Chool Kim CEO
 Chief Executive Officer 67 12-03-31
Yun-Gyeong Bae CTO
 Chief Tech/Sci/R&D Officer 60 -
Jong-Su Gang BRD
 Director/Board Member 60 -
Sung-Ho Kang SAM
 Sales & Marketing 58 -
Min-Cheol Jeong AUD
 Comptroller/Controller/Auditor 67 -

Members of the board

Members of the board TitleAgeSince
Jung-Chool Kim CEO
 Chief Executive Officer 67 12-03-31
Jong-Su Gang BRD
 Director/Board Member 60 -
Yun-Gyeong Bae CTO
 Chief Tech/Sci/R&D Officer 60 -
Dong-chul Shin BRD
 Director/Board Member 63 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 66,575,469 62,159,495 ( 93.37 %) 822,388 ( 1.235 %) 93.37 %

Shareholders

NameEquities%Valuation
APROGEN MEDICINES INC.
5.377 %
35,795,470 5.377 % 5 M ₩
APROGEN BIOLOGICS INC.
1.235 %
8,223,876 1.235 % 1 M ₩
Dimensional Fund Advisors Ltd.
0.0427 %
284,447 0.0427 % 40 346 ₩
Jung-Chool Kim
0.003286 %
21,880 0.003286 % 3 103 ₩
DFA Australia Ltd.
0.002719 %
18,099 0.002719 % 2 567 ₩
Mirae Asset Global Investments Co., Ltd.
0.002409 %
16,036 0.002409 % 2 275 ₩
Sung Nao
0.001779 %
11,844 0.001779 % 1 680 ₩
Seong-ho Kang
0.000929 %
6,182 0.000929 % 877 ₩
Jong-Su Gang
0.000493 %
3,282 0.000493 % 466 ₩
An-soo Kim
0.000329 %
2,188 0.000329 % 310 ₩

Holdings

NameEquities%Valuation
AP HEALTHCARE INC.
42.00%
 47,945,206 42.00% 22,116,165 $
APROGEN BIOLOGICS INC.
1.24%
 8,223,876 1.24% 1,166,475 $
APROGEN MEDICINES INC.
-.--%
 0 -.--% 0 $

Company contact information

Aprogen Biologics, Inc.

Room 301 Gangho Building 6 Ogeum-ro 19-gil

06735, Seoul

+

http://www.aprogen-pharm.com
address Aprogen Biologics Inc.(A003060)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
APROGEN BIOLOGICS INC. Stock Aprogen Biologics Inc.
-46.03% 74.76M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A003060 Stock
  4. Company Aprogen Biologics Inc.